NCT06317272终止不适用
BReath hOld TecHniquEs for Radiotherapy of Esophageal Carcinoma; a Feasibility Study - Part 1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 1
- 试验地点
- 1
- 主要终点
- Reproducibility DIBH
研究概览
简要总结
The main objective of the first part of the study is to determine the most optimal method for DIBH (active breathing control vs voluntary coached) and its reproducibility. Based on these findings, one of these methods will be selected for part 2 of this study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Sequential
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically proven esophageal cancer of the mid or distal esophagus
- •Scheduled for external-beam photon radiotherapy with curative intention.
- •Age >= 18 years
- •Written informed consent.
排除标准
- •Serious respiratory distress
- •Contra-indication for fiducial marker placement
- •Noncompliance with any of the inclusion criteria
结局指标
主要结局
Reproducibility DIBH
时间窗: Week 1, 2, 3, 4, 5 during radiotherapy
Diaphragm dome position within 1cm of the baseline CT Target coverage \>94% of the prescribed dose (at 98% of the ITV)
Feasibility DIBH
时间窗: Week 1, 2, 3, 4, 5 during radiotherapy
Breath hold maintained for \>20 seconds
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Combined Deep Inspiration Breath Hold (DIBH)-Expiration Planning Technique in Patients With Lung Tumors in Close Proximity to the Chest WallMetastatic CancerLung CancerNCT04507828Indiana University4
撤回
不适用
Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot StudyLung CancerNCT00585819University of Wisconsin, Madison
已完成
不适用
Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung CarcinomasLung CancerEsophageal CancerNCT02497664University Medical Center Groningen22
已完成
不适用
Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic ResectionEsophageal CancerNCT05499195Chinese Academy of Medical Sciences159
已完成
1 期
Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersMetastaticNon Small Cell Lung Cancer (NSCLC)Breast CancerPancreatic CancerMelanomaNCT02639026Abramson Cancer Center at Penn Medicine53